Showing 32 of 32 results

Niger Government
Niger_Rapport RIA Vaccination COVID-19 (IAR),Niger_Rapport RIA Vaccination COVID-19 (IAR)
World Health Organization (WHO)
Niger: Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention,Niger: Analyse de...
Dalia Khattab, Francis Mwansa, Freddy Nkosi, Olamide Folorunso, Wendy Prosser
In this session you will hear from several countries that have taken a system design approach to improve the performance of their immunization supply chains. Zambia and DRC have both changed...
World Health Organization (WHO)
Niger has reported a new polio outbreak that has affected two children in Niamey and Tillaberi region, the World Health Organization (WHO) said today (April 2020).
MoH Niger
Dans le cadre de l’organisation et de la continuité de l’offre de service de vaccination en période de cette pandémie ; la Direction des Immunisations (DI) du Ministère de la santé publique...
Home-based record (HBR) for Niger circa 2013
Home-based record (HBR) for Niger circa 1999
Home-based record (HBR) for Niger circa 2010
World Health Organization (WHO)
From 24-30 April 2016, countries in the African Region commemorated the 6th African Vaccination Week (AVW).The goal of AVW is to strengthen immunization programmes in the African...
PATH
This fact sheet describes PATH’s efforts to eliminate meningococcal meningitis epidemics from Africa, once and for all. It covers work across meningitis projects, including the development and...
Caroline L Trotter et al.
Background: In preparation for the introduction of MenAfriVac, a meningococcal group A conjugate vaccine developed for the African meningitis belt, an enhanced meningitis surveillance network was...
Sheila Isanaka et al.
Background: Each year, rotavirus gastroenteritis is responsible for about 37% of deaths from diarrhea among children younger than 5 years of age worldwide, with a disproportionate effect in...
Nnadi C et al.
On August 10, 2016, 2 years after the most recent wild poliovirus (WPV) case was reported in Nigeria (in July 2014) (1), two WPV cases were reported in the northeastern state of Borno, which has been...
Mable Carole Tevi-Benissan et al.
Background Significant progress has been made to increase access to vaccines in Africa since the 1974 launch of the Expanded Programme on Immunization (EPI). Successes include the introduction of...
Etienne Minkoulou, Pascal Mkanda, Richard Mihigo, Joseph Okeibunor, Landoh Dadja, Peter Gaturuku, Ali Yahaya, Keith Shaba, Alain Poy
Introduction The PEI Programme in the WHO African region invested in recruitment of qualified staff in data management, developing data management system and standards operating systems since the...
Tina-Marie Assi et al.
Background Many countries, such as Niger, are considering changing their vaccine vial size presentation and may want to evaluate the subsequent impact on their supply chains, the series of steps...
Kim
Vaccination coverage surveys - Publication abstract: MenAfriVac is a new conjugate vaccine against Neisseria meningitidis serogroup A developed for the African \"meningitis belt\". In Niger, the...
Grais
Vaccination coverage surveys - Publication abstract: In two-stage cluster surveys, the traditional method used in second-stage sampling (in which the first household in a cluster is selected) is...
Caini
Vaccination coverage surveys - Publication abstract: MenAfriVac™ is a conjugate vaccine against meningitis A specifically designed for Africa. In Niger, the MenAfriVac™ vaccination campaign...
World Health Organization (WHO)
This report highlights the achievements made in expanding access to vaccines in Africa and discusses some of the remaining challenges to achieving universal access to vaccines. The timing of this...
Michael Favin et al.
In collaboration with WHO, IMMUNIZATIONbasics analyzed 126 documents from the global grey literature to identify reasons why eligible children had incomplete or no vaccinations. The main reasons for...
World Health Organization (WHO)
This report, prepared by the Secretariat for the Decade of Vaccines Global Vaccine Action Plan, serves as the basis for the independent review. As was the case in 2013 and 2014, this report reviews...
Carl E. Frasch et al.
Although many years of application of meningococcal polysaccharide vaccines have had minimal success in preventing meningococcal epidemics in the meningitis belt of Africa, collaborative efforts to...
Kathleen Tiffay et al.
The development, through a public–private partnership, of a safe, effective, and affordable vaccine for sub-Saharan Africa, PsA-TT, offers a new paradigm for the development of vaccines...
M. Teresa Aguado et al.
In June 2001, BMGF awarded a grant of US$70 million to create the Meningitis Vaccine Project (MVP) as a partnership between PATH and WHO, with the specific goal of developing an affordable MenA...
Tina-Marie Assi et al.
Switching from the 10-dose to the 5-dose, 2-dose and 1-dose vial sizes decreased the average availability of EPI vaccines for arriving patients from 83% to 82%, 81% and 78%, respectively for a 100%...
Tina-Marie Assi et al.
Removing the regional level and implementing a collection-based shipping policy from the district stores increases vaccine availability from a mean of 70–100% when districts could collect vaccines...
Jean-Marc Collard et al.
The epidemiology of pneumococcal meningitis in the African ‘meningitis belt’ is poorly studied. In order to ensure an effective vaccination strategy and post-vaccination surveillance, the...
International Vaccine Access Center (IVAC)
The following report displays data and figures on the introduction status of Hib vaccine, pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV)* both globally...
James L. Goodson et al.
Rubella virus infection is transmitted by respiratory droplets and causes a generally mild disease characterized by a rash and fever, primarily in children. However, infection in women during early...
Halima Boubacar Maïnassara et al.
To inform epidemic response strategies for the African meningitis belt after a meningococcal serogroup A conjugate vaccine was introduced in 2010, the researchers compared the effectiveness and...